236 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (1001)
- Addiction (14)
- Allergy, Asthma, & Immunology (11)
- All of Us Research Program - NIH (1)
- Autoimmune Disorders (25)
- Blood Disorders (18)
- Bone & Muscle (8)
- Cancer (90)
- Child Development (4)
- COVID-19 (Coronavirus) (28)
- Critical Illness (1)
- Diabetes (13)
- Ear, Nose and Throat (5)
- Endocrine & Metabolic Disease (11)
- Eye (7)
- Gastrointestinal and Digestive Diseases (23)
- Hair and Skin Disorders (2)
- Headaches (5)
- Healthy Volunteers (142)
- Heart Disease (111)
- Infectious Disease (40)
- Insomnia (2)
- Kidney Disease (12)
- Liver Disease (43)
- Lung Disease (29)
- Meniere's Disease (1)
- Neurological Disorders (96)
- Nutrition (3)
- Obesity (2)
- Obstetrics & Gynecology (46)
- Pain Management (1)
- Pediatrics (83)
- Psychiatric Disorders (60)
- Rehabilitation (7)
- Stroke (5)
- Surgery (7)
- Transplant (33)
- Urology (3)
- Vascular Conditions (9)
Displaying 1 - 3 of 3
Condition: Cancer / Multiple Myeloma
Investigator: Divaya Bhutani, MD
Status: Closed
The purpose of this study is to see how teclistamab by itself compares to study treatment combinations that are commonly used to treat multiple myeloma. These study treatment combinations are either pomalidomide, bortezomib and dexamethasone (called PVd) or carfilzomib and dexamethasone (called Kd). The patients will be randomly assigned to one of the study…
Condition: Cancer / Multiple Myeloma
Investigator: Suzanne Lentzsch, MD
Status: Closed
We are doing this study to learn if the MMprofiler test can help your doctor in making decisions about your treatment. The MMprofiler genomic test will look at a large number of normal genes. The test will predict risk of your multiple myeloma (MM) by assessing whether these genes are turned on or off in your cancer cells. The purpose of this research is to…
Condition: Addiction / Alcohol
Investigator: Gene Im, MD, FAASLD
Status: Closed
Researchers at Columbia University Irving Medical Center are investigating whether the investigational medication efimosfermin is safe and effective in improving outcomes for adults with Alcohol-related Liver Disease (ALD). ALD refers to liver damage caused by heavy alcohol consumption. The study uses a placebo for comparison because there are no approved…